Fitbit and Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced a collaboration to study the potential of wearable devices to improve metabolic health, which influences risk of developing several diseases, including diabetes and heart disease.
January 17, 2024
· 5 min read